BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 7336100)

  • 21. [Action of the basic trypsin inhibitor on lymphocyte blastic transformation in vitro].
    Camerini G; Menegatti E; Menghi P; Scorrano M
    Boll Ist Sieroter Milan; 1981 Jul; 60(3):212-5. PubMed ID: 7326096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transforming potentials of lymphocytes in physiological and some pathological conditions].
    Popova L
    Vutr Boles; 1973; 12(3):62-70. PubMed ID: 4752619
    [No Abstract]   [Full Text] [Related]  

  • 23. "Killer"-type phenomena in the immune pathology of some chronic internal diseases. (Scanning electron microscopy studies).
    Micu D; Manolescu N
    Med Interne; 1982; 20(3):245-7. PubMed ID: 7156819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lymphocyte transformation during immunosuppressive therapy of lupus erythematosus visceralis].
    Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:152-4. PubMed ID: 5402572
    [No Abstract]   [Full Text] [Related]  

  • 25. [Blastic transformation of lymphocytes in culture stimulated by phytohemagglutinin (PHA) in hypoplastic anemia and lymphoproliferative diseases].
    Samoĭlina NL; Polianskaia AM
    Probl Gematol Pereliv Krovi; 1969 Oct; 14(10):3-13. PubMed ID: 4983365
    [No Abstract]   [Full Text] [Related]  

  • 26. Defective control of ribosomal RNA processing in stimulated leukemic lymphocytes.
    Rubin AD
    J Clin Invest; 1971 Dec; 50(12):2485-97. PubMed ID: 5129303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proceedings: Impaired cell-mediated immunity in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
    Paty JG; Sienknecht CW; Townes AS; Hanissian AS; Masi AT
    Arthritis Rheum; 1974; 17(3):324. PubMed ID: 4825653
    [No Abstract]   [Full Text] [Related]  

  • 28. Microinterferometric measurement of dry weight of blood lymphocytes in hematologically normal patients and in patients with chronic lymphocytic leukemia.
    Efrati P; Sakal E; Nir N
    Acta Cytol; 1977; 21(4):539-42. PubMed ID: 269604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressor T cell activity in rheumatoid arthritis and systemic lupus erythematosus.
    Sakane T; Taniguchi Y; Honda M; Kotani H
    Ryumachi; 1981; 21 Suppl():115-22. PubMed ID: 6211784
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical significance of the lymphocyte transformation test].
    Urasiñski I; Lisiewicz J
    Pol Tyg Lek; 1971 Jul; 26(29):1124-7. PubMed ID: 4941500
    [No Abstract]   [Full Text] [Related]  

  • 31. [Transformation of lymphocytes during immunosuppressive therapy in lupus erythematosus visceralis].
    Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C
    Z Gesamte Inn Med; 1969 May; 24(10):152-4. PubMed ID: 5812420
    [No Abstract]   [Full Text] [Related]  

  • 32. [Blastic transformation of lymphocytes induced with phytohemagglutinin in patients with rheumatoid arthritis].
    Celińska-Szpytko E; Mackiewicz S
    Pol Tyg Lek; 1974 May; 29(19):769-70. PubMed ID: 4848142
    [No Abstract]   [Full Text] [Related]  

  • 33. [Nonspecific cell-mediated immunity in chronic hepatitis studied in vitro].
    Popova L
    Vutr Boles; 1976; 15(2):53-61. PubMed ID: 936590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of interleukin-2 on peripheral lymphocytes and monocytes. III. Proliferative and cytotoxic effects in vitro in patients with systemic erythematosus and progressive polyarthritis].
    Jíra M; Strejcek J; Zavadil Z; Antosová E; Rejholec V
    Cas Lek Cesk; 1988 Dec; 127(52):1609-12. PubMed ID: 3265892
    [No Abstract]   [Full Text] [Related]  

  • 35. T lymphocytes in chronic lymphocytic leukemia.
    Rozynkowa D; Rupniewska Z; Stepien J
    Ann Med Sect Pol Acad Sci; 1976; (3):121-38. PubMed ID: 1086046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis.
    Polgár A; Brózik M; Tóth S; Holub M; Hegyi K; Kádár A; Hodinka L; Falus A
    Med Sci Monit; 2000; 6(1):13-8. PubMed ID: 11208277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical importance of blastic transformation of lymphocytes in chronic lymphatic leukemia].
    Holowiecki J
    Acta Haematol Pol; 1972; 3(3):237-43. PubMed ID: 4649306
    [No Abstract]   [Full Text] [Related]  

  • 39. [Quantitative evaluation of the immunoglobulin-synthesizing function of the peripheral lymphocytes in rheumatoid arthritis, systemic lupus erythematosus and rheumatism].
    Benenson EV; Panov VG; Seĭsenbaev ASh; Sagandykov BB
    Ter Arkh; 1982; 54(6):37-40. PubMed ID: 6810488
    [No Abstract]   [Full Text] [Related]  

  • 40. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
    Dejica DI; Manea EM
    Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.